INDIES reports a 16% decrease in first quarter net profits
Rochelle Muncey2020-03-16T17:55:01-05:00March 16, 2020 Indies Pharma Jamaica Limited reported revenue of $193.72 million, 15% higher than the $168.18 million booked in 2019. Cost of Sales increased 32% to close at $65.86 million (2019: $49.94 million). Gross profit increased by 8%, amounting to $127.86 million for the period relative to $118.24 million in 2019. Other operating income